LENA DRAUS: Open Payments
NPI 1891376422 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 30 payments from 12 companies in 2025. Trend: 2023 $619 · 2024 $727 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 10 | $436 |
| Novo Nordisk Inc | 4 | $86 |
| Endo USA, Inc. | 3 | $73 |
| Tandem Diabetes Care, Inc. | 3 | $65 |
| Ascendis Pharma Endocrinology Inc | 2 | $43 |
| Sequel Med Tech, LLC | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $35 |
| PFIZER INC. | 1 | $25 |
| ABBVIE INC. | 1 | $20 |
| TOLMAR, INC. | 1 | $18 |
Products named: Dexcom G6 Transmitter, Sogroya, SUPPRELIN, t:slim X2 Insulin Pump with Control-IQ, Skytrofa, TWIIST, CRENESSITY, GENOTROPIN.
Industry payments across IL — which companies pay providers there.
